Table 4.
4A. | Univariate
|
Multivariable
|
||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Total
|
Exclude vaccinated patients
|
Total
|
Exclude vaccinated patients
|
|||||||||
Unadjusted Odds Ratio | 95% CI | Wald p value | Unadjusted Odds Ratio | 95% CI | Wald p value | Adjusted Odds Ratio | 95% CI | Wald p value | Adjusted Odds Ratio | 95% CI | Wald p value | |
HER2 Status | ||||||||||||
HER2+ vs. HER2− | 4.01 | 1.73–9.34 | 0.001 | 3.99 | 1.47–10.82 | 0.007 | 4.15 | 1.56–11.04 | 0.004 | 3.43 | 0.98–12.02 | 0.06 |
| ||||||||||||
ER Status | ||||||||||||
ER− vs. ER+ | 1.59 | 0.67–3.82 | 0.30 | 2.53 | 0.92–6.96 | 0.07 | 0.54 | 0.19–1.58 | 0.26 | 0.94 | 0.24–3.65 | 0.93 |
| ||||||||||||
Grade | ||||||||||||
Intermediate vs.Low | 1.79 | 0.20–16.12 | 0.15 | 1.54 | 0.17–14.28 | 0.44 | 2.26 | 0.24–21.61 | 0.36 | 1.84 | 0.19–18.07 | 0.75 |
High vs. Low | 3.92 | 0.48–32.19 | 2.71 | 0.32–23.14 | 3.80 | 0.42–34.00 | 2.30 | 0.24–21.70 |
4B. | Univariate
|
Multivariable
|
||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Total
|
Exclude vaccinated patients
|
Total
|
Exclude vaccinated patients
|
|||||||||
Unadjusted Odds Ratio | 95% CI | Wald p value | Unadjusted Odds Ratio | 95% CI | Wald p value | Adjusted Odds Ratio | 95% CI | Wald p value | Adjusted Odds Ratio | 95% CI | Wald p value | |
Phenotype | ||||||||||||
ER/PR+/HER2− | 1.00# | 0.013 | 1.00# | 0.05 | 1.00# | 0.04 | 1.00# | 0.19 | ||||
ER/PR/HER2+ | 4.87 | 1.72–13.74 | 3.13 | 0.69–14.10 | 4.53 | 1.55–13.22 | 3.17 | 0.67–14.95 | ||||
ER/PR−/HER2+ | 3.46 | 1.23–9.71 | 4.65 | 1.46–14.75 | 2.35 | 0.76–7.26 | 3.46 | 0.96–12.51 | ||||
ER/PR/HER2− | 1.22 | 0.13–11.18 | 1.22 | 0.13–11.18 | 0.94 | 0.10–8.93 | 1.06 | 0.11–10.23 | ||||
| ||||||||||||
Grade | ||||||||||||
Intermediate vs. Low | 1.79 | 0.20–16.12 | 0.15 | 1.54 | 0.17–14.28 | 0.44 | 2.29 | 0.24–22.13 | 0.39 | 1.78 | 0.18–17.64 | 0.78 |
High vs. Low | 3.92 | 0.48–32.19 | 2.71 | 0.32–23.14 | 3.69 | 0.41 0 33.22 | 2.18 | 0.23–20.52 |
Referent category